Synthego Receives $41,000,000 Series B Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fa936278-768f-4a57-b6b7-9aa42102f34a - Date
1/5/2017 - Company Name
Synthego - Mailing Address
3696 Haven Ave Redwood City, CA 94063 USA - Company Description
Founded by former SpaceX engineers, Synthego is a leading provider of genome engineering solutions. The company’s flagship product, CRISPRevolution, is a portfolio of synthetic RNA designed for CRISPR genome editing and research. - Website
http://www.synthego.com - Transaction Type
Venture Equity - Transaction Amount
$41,000,000 - Transaction Round
Series B - Proceeds Purposes
The funds will be used for growth of commercial operations, international expansion, and introduction of new products. - M&A Terms
- Venture Investor
8VC - Venture Investor
AME Cloud Ventures - Venture Investor
Element Partners - Venture Investor
OS Fund - Venture Investor
Alexandria Venture Investments - Venture Investor
ZhenFund - Venture Investor
Investor
